ARCHIVES

Gerstner Resigns From NA, MSK Board After Taking RJR Job

This article is from The Cancer Letter archive.

Vol. 15 No. 12 | March 24, 1989

Download PDF Visit The Full Archive

Related Articles

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013